These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35169101)

  • 1. [Precision Medicine for Moyamoya Disease].
    Fujimura M
    No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 4. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
    Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.
    Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T
    Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
    Park MG; Shin JH; Lee SW; Park HR; Park KP
    J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
    Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
    Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
    Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
    Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
    Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
    Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213.
    Inoue T; Murakami N; Sakadume S; Kido Y; Kikuchi A; Ichinoi N; Suzuki K; Kure S; Sakuta R
    Pediatr Int; 2015 Aug; 57(4):798-801. PubMed ID: 26315205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease.
    Ishisaka E; Watanabe A; Murai Y; Shirokane K; Matano F; Tsukiyama A; Baba E; Nakagawa S; Tamaki T; Mizunari T; Tanikawa R; Morita A
    Neurosurg Focus; 2021 Sep; 51(3):E2. PubMed ID: 34469872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Ring Finger Protein 213 in Moyamoya Disease.
    Ma YG; Zhang Q; Yu LB; Zhao JZ
    Chin Med J (Engl); 2016 Oct; 129(20):2497-2501. PubMed ID: 27748344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Development of Moyamoya Disease after Stereotactic Radiosurgery for Brain Arteriovenous Malformation in a Patient With RNF213 p.Arg4810Lys (rs112735431).
    Torazawa S; Miyawaki S; Shinya Y; Kawashima M; Hasegawa H; Dofuku S; Uchikawa H; Kin T; Shin M; Nakatomi H; Saito N
    World Neurosurg; 2020 Aug; 140():276-282. PubMed ID: 32434013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease.
    Kawabori M; Ito M; Kazumata K; Tokairin K; Hatanaka KC; Ishikawa S; Houkin K; Fujimura M
    Cerebrovasc Dis; 2023; 52(2):171-176. PubMed ID: 36063804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.